New Born Screening (NBS)

The NBS lab at Neuberg Ehrlich can handle more than a 100 tests a day with over 30 different parameters of inborn errors being screened in new born children. Multiple technologies like fluorimetry and ELISA help in arriving at a detection in these cases. Positive cases can be confirmed by our next generation sequencing technology in-house,making it a one stop shop for diseases of the new born. The newly launching Lysosomal Storage Disorder (LSD) screening tests within the same lab follow the same principle by providing an end-point solution for the rarest of enzyme deficiency disorderssuch as MPS1, Gauchers Disease, Pompeiis Disease, Taysachs and Neimannpiks Diseases.